FBC
CELG

Fairfield, Bush & Co’s Celgene Corp CELG Stock Holding History

Fairfield, Bush & Co’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-15,265
Closed -$1.52M – 155
2019
Q3 		$1.52M Hold
15,265
– – 0.52% 48
2019
Q2 		$1.41M Sell
15,265
-1,945
-11% -$185K 0.48% 49
2019
Q1 		$1.62M Buy
17,210
+150
+0.9% +$13.1K 0.54% 46
2018
Q4 		$1.09M Sell
17,060
-1,450
-8% -$107K 0.38% 52
2018
Q3 		$1.66M Buy
18,510
+2,700
+17% +$239K 0.46% 50
2018
Q2 		$1.26M Sell
15,810
-1,760
-10% -$146K 0.37% 56
2018
Q1 		$1.57M Buy
17,570
+1,545
+10% +$148K 0.46% 49
2017
Q4 		$1.67M Buy
16,025
+2,945
+23% +$332K 0.46% 49
2017
Q3 		$1.91M Hold
13,080
– – 0.6% 40
2017
Q2 		$1.7M Hold
13,080
– – 0.54% 44
2017
Q1 		$1.63M Hold
13,080
– – 0.51% 45
2016
Q4 		$1.51M Hold
13,080
– – 0.49% 48
2016
Q3 		$1.37M Sell
13,080
-655
-5% -$70.9K 0.44% 51
2016
Q2 		$1.35M Buy
13,735
+3,200
+30% +$331K 0.47% 47
2016
Q1 		$1.05M Sell
10,535
-1,125
-10% -$116K 0.38% 51
2015
Q4 		$1.4M Buy
11,660
+6,155
+112% +$712K 0.49% 50
2015
Q3 		$595K Sell
5,505
-2,350
-30% -$292K 0.26% 68
2015
Q2 		$909K Buy
7,855
+75
+1% +$8.57K 0.27% 75
2015
Q1 		$897K Buy
7,780
+520
+7% +$62.1K 0.26% 78
2014
Q4 		$812K Buy
7,260
+4,900
+208% +$517K 0.23% 82
2014
Q3 		$224K Buy
+2,360
New +$213K 0.06% 162

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Fairfield, Bush & Co's CELG Position: Q4 2019 in Review

Fairfield, Bush & Co sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 15,265 shares — an estimated $1.52M sold.

Fairfield, Bush & Co first reported a position in CELG in Q3 2014 and held it in 21 quarters. The position peaked at $1.91M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Fairfield, Bush & Co reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Fairfield, Bush & Co sold 15,265 Celgene Corp shares in Q4 2019, an estimated $1.52M.
  • Fairfield, Bush & Co first reported a position in Celgene Corp in Q3 2014 and held it in 21 quarters.
  • Fairfield, Bush & Co's Celgene Corp position peaked at $1.91M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Fairfield, Bush & Co's 13F filing for Q4 2019, filed 12 Feb 2020.